---
title: "The concept of innovative drugs has strengthened again, with Hotgen rising over 10% to reach a new historical high"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251738294.md"
description: "In the morning session, the innovative drug concept strengthened again, with Hotgen rising over 10%, reaching a historical high. Junshi Biosciences and Hongbo Medicine also rose over 10%, while Chenxin Pharmaceutical, KHPG, HITECK, BIO-THERA, and JENKEM followed suit"
datetime: "2025-08-06T01:39:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251738294.md)
  - [en](https://longbridge.com/en/news/251738294.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251738294.md)
---

# The concept of innovative drugs has strengthened again, with Hotgen rising over 10% to reach a new historical high

In the early trading session, the innovative drug concept strengthened again, with Hotgen rising over 10%, reaching a historical high. Junshi Biosciences and Hongbo Pharmaceutical also rose over 10%, while Chenxin Pharmaceutical, KHPG, HITECK, BIO-THERA, and JENKEM followed suit

### Related Stocks

- [002773.CN](https://longbridge.com/en/quote/002773.CN.md)
- [688068.CN](https://longbridge.com/en/quote/688068.CN.md)
- [300683.CN](https://longbridge.com/en/quote/300683.CN.md)
- [688177.CN](https://longbridge.com/en/quote/688177.CN.md)
- [688356.CN](https://longbridge.com/en/quote/688356.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Hisense Home Appliances Deploys RMB1.81 Billion into Chongqing Trust Wealth Products](https://longbridge.com/en/news/286888326.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Indonesia’s investment app Pluang raises $10M, expands into equities marketGrows**](https://longbridge.com/en/news/286855201.md)